Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Rachel Bridson
Introduction
The key aim of any pharmaceutical manufacturing process is to produce a SAFE, PURE and EFFICACIOUS product
To ensure that this aim is met, quality assurance procedures must be in place
Definition of QA
..the sum total of the organised arrangements made with the object of ensuring that medicinal products are of the quality required for their intended use Directive 91/356/EEC
GMP
QC
Production / control operations are clearly defined Managerial / team responsibilities are clearly defined Correct materials are used In-process controls and validation are carried out Finished product is correctly processed Storage and handling are appropriate Self-inspection and audit procedures exist
Definition of GMP
good manufacturing practice shall mean that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use.
GMP
Demands that: All critical steps within the process are defined and validated Only approved procedures are followed Detailed documentation is produced to ensure full traceability Overall objective is to ensure that the material consumed by the end user has the following defined attributes: Purity Strength Identity
GMP: Personnel
Should be competent, appropriately qualified and in sufficient numbers Everyone should have a clearly defined job description Hierarchical relationships should be shown on an organisational chart Initial and continuing training should be provided Personnel must follow established hygiene protocols
Should be entirely suitable for the intended operations Lay out, design and operation must minimise risk of errors, cross-contamination and anything that may have an adverse effect on the product Premises and equipment that are critical for product quality will be validated (qualified)
Premises cont.
Each site will have its own unique constraints and problems: history neighbours security topography utility
access
GMP: documentation
Should be clear, up to date and accurate Must allow the history of each batch to be fully traced Should be retained for the specified period Data storage systems must validated and adequately backed-up
SPECIFICATIONS REAGENTS
IN-PROCESS SAMPLES RECORDS AUDIT REPORTS
BATCH DOCUMENTATION
cGMP: production
All operations should be carried out according to pre-established instructions Process modifications must be validated Critical phases of the manufacturing process should be regularly re-validated Measures must be taken to avoid cross contamination and mix-ups Adequate and sufficient resources must be made available for in-process controls
An independent QC department must be set up and placed under the control of a QP At least one, appropriately staffed and equipped lab must be available
Responsibilities of QC personnel
Monitor facilities for cleanliness Monitor manufacturing personnel hygiene Evaluate raw materials, packaging materials, intermediates and final product identity Perform product safety testing and final product release procedures
Must be subject to a written contract the contract acceptor must not then pass on work to a further party without written authorisation Contract must state all responsibilities and the manner in which those responsibilities will be met Contract acceptor must follow GMP and be subject to the necessary inspections
The manufacturer must have a procedure for recording and evaluating complaints An effective recall system should be in place The competent authority should be informed of any defects
GMP: self-inspection
As part of the QA system the manufacture must perform regular self-inspections to ensure that all guidelines and GMP principles are being followed Records should be kept of the results and subsequent corrective actions
Validation
Programme designed to identify, prove and document that your product consistently meets your specifications and quality attributes
it must be kept as simple as possible it must identify and deal with what is critical it must not validate what does not matter
documentation is required
of performance factors
Consistency Measured
set expectations
Validation types
Prospective
new facilities, equipment or products working process which can be used as benchmark historical performance data or observations
On-going
Retrospective
Cost of GMP ?
Difficult to quantify: it
it
it
And finally.
Pharmaceutical companies are increasingly outsourcing more of their manufacturing, research and clinical trial operations
Supply companies as well as pharmaceutical companies must embrace GMP to secure future business